Empagliflozin Improves Kidney Outcomes Irrespective of Control of Blood Pressure, Low-Density Lipoprotein Cholesterol and HbA1c - Wanner, C; Cooper, M; Inzucchi, S; Zinman, B; Zwiener, I; Eynatten, M von; Koitka-Weber, A (Diabetologie und Stoffwechsel, 2019)